Does UPADACITINIB Cause Ankylosing spondylitis? 117 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 117 reports of Ankylosing spondylitis have been filed in association with UPADACITINIB (Rinvoq). This represents 0.2% of all adverse event reports for UPADACITINIB.
117
Reports of Ankylosing spondylitis with UPADACITINIB
0.2%
of all UPADACITINIB reports
0
Deaths
16
Hospitalizations
How Dangerous Is Ankylosing spondylitis From UPADACITINIB?
Of the 117 reports, 16 (13.7%) required hospitalization.
Is Ankylosing spondylitis Listed in the Official Label?
Yes, Ankylosing spondylitis is listed as a known adverse reaction in the official FDA drug label for UPADACITINIB.
What Other Side Effects Does UPADACITINIB Cause?
Pain (4,444)
Arthralgia (3,815)
Drug ineffective (3,384)
Covid-19 (2,978)
Rheumatoid arthritis (2,730)
Pain in extremity (2,353)
Fatigue (2,153)
Fall (2,081)
Surgery (2,037)
Therapy interrupted (1,741)
What Other Drugs Cause Ankylosing spondylitis?
CERTOLIZUMAB PEGOL (2,580)
ADALIMUMAB (2,378)
SECUKINUMAB (1,942)
ETANERCEPT (1,456)
METHOTREXATE (1,067)
DICLOFENAC (874)
INFLIXIMAB (789)
GOLIMUMAB (643)
LEFLUNOMIDE (413)
CELECOXIB (329)
Which UPADACITINIB Alternatives Have Lower Ankylosing spondylitis Risk?
UPADACITINIB vs URAPIDIL
UPADACITINIB vs UREA
UPADACITINIB vs URIDINE TRIACETATE
UPADACITINIB vs UROFOLLITROPIN
UPADACITINIB vs URSODIOL